Showcases Stock ranks Forex

Moderna Inc. (MRNA)
69.87  1.98 (2.92%) 09-18 16:00
Open: 68.28 Pre. Close: 67.89
High: 70 Low: 66.1
Volume: 13,206,193 Market Cap: 27,570M
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). The company is headquartered in Cambridge, Massachusetts and currently employs 760 full-time employees. The company has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technologies, delivery technologies, and manufacturing processes. The company is pursuing mRNA science to minimize the undesirable activation of the immune system by mRNA and to maximize the potency of mRNA once in the target cells. The company has advanced in parallel a diverse development pipeline of 21 programs, of which 10 have entered clinical studies and another three have open INDs. Its therapeutics and vaccine development programs span infectious diseases, oncology, cardiovascular diseases, and rare genetic diseases. The company has created six modalities prophylactic vaccines, cancer vaccines, intratumoral immmuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics and systemic intracellular therapeutics.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 68.431 - 68.633 68.633 - 68.86
Low: 63.637 - 63.875 63.875 - 64.142
Close: 66.447 - 66.818 66.818 - 67.232
Stock Technical Analysis
Target: Six months: 88.48
One year: 103.34
Support: Support1: 62.44
Support2: 54.21
Resistance: Resistance1: 75.75
Resistance2: 88.48
Pivot: 63.42
Moving Averages: MA(5): 60.87
MA(20): 64.28
MA(100): 65.34
MA(250): 39.41
MACD: MACD(12,26): -2.42
Signal(12,26,9): -2.68
%K %D: %K(14,3): 52.13
%D(3): 35.93
RSI: RSI(14): 52.40
52-Week: High: 95.21
Low: 13.53
Change(%): 276.2
Average Vol(K): 3-Month: 2047675
10-Days: 1017467
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.

MRNA has closed below upper band by 30.4%. Bollinger Bands are 14% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
Fri, 18 Sep 2020
3 Moderna Analyst Takes On The Coronavirus Vaccine Developer's Pipeline - Yahoo Finance

Wed, 16 Sep 2020
Moderna, Inc.: All Signs Point To An Impending Rally - Seeking Alpha

Mon, 14 Sep 2020
Moderna's Late-Stage Coronavirus Vaccine Study Hits 78% Enrollment - Benzinga

Mon, 14 Sep 2020
Implied Volatility Surging for Moderna (MRNA) Stock Options - Yahoo Finance

Thu, 10 Sep 2020
Moderna Inc. (NASDAQ:MRNA) is in talks with Japan to Sell 40 Million Doses of its Coronavirus Vaccine mRNA-1273 - BP Journal

Wed, 09 Sep 2020
Hedge Funds Keep Piling Into Moderna, Inc. (MRNA) - Yahoo Finance

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  NasdaqGS
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 394.59
Shares Float (M) 307.49
% Held by Insiders 23.94
% Held by Institutions 53.53
Shares Short (K) 28020
Shares Short Prior Month (K) 27190
Stock Financials
EPS -1.390
Book Value (p.s.) 7.490
Profit Margin
Operating Margin -485.03
Return on Assets (ttm) -12.4
Return on Equity (ttm) -22.8
Qtrly Rev. Growth 407.2
Gross Profit (p.s.) -1.105
Sales Per Share 0.268
EBITDA (p.s.) -1.222
Qtrly Earnings Growth
Operating Cash Flow (M) -336.18
Levered Free Cash Flow (M) -303.82
Stock Valuation
PE Ratio -48.12
PEG Ratio
Price to Book value 8.93
Price to Sales 249.34
Price to Cash Flow -78.50
Stock Dividends
Dividend Yield
Dividend Growth

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator